The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
β-Lactamases: A Focus on Current Challenges
Open accessAbstract
β-Lactamases, the enzymes that hydrolyze β-lactam antibiotics, remain the greatest threat to the usage of these agents. In this review, the mechanism of hydrolysis is discussed for both those enzymes that use serine at the active site and those that require divalent zinc ions for hydrolysis. The β-lactamases now include >2000 unique, naturally occurring amino acid sequences. Some of the clinically most important of these are the class A penicillinases, the extended-spectrum β-lactamases (ESBLs), the AmpC cephalosporinases, and the carbapenem-hydrolyzing enzymes in both the serine and metalloenzyme groups. Because of the versatility of these enzymes to evolve as new β-lactams are used therapeutically, new approaches to antimicrobial therapy may be required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Self-citationKumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Self-citationCarbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Self-citationAn Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-06 · Cited by 480
Self-citation“Stormy waters ahead”: global emergence of carbapenemases
Patel, G., & Bonomo, R. A. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00048 · Cited by 423
Self-citationKinship and Diversification of Bacterial Penicillin-Binding Proteins and β-Lactamases
Massova, I., & Mobashery, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.1 · Cited by 422
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Bush, K. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.006 · Cited by 398
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. (1988) · PubMed · Cited by 341
DeLeo, F. R., Chen, L., Porcella, S. F., Martens, C. A., Kobayashi, S. D., Porter, A. R., Chavda, K. D., Jacobs, M. R., Mathema, B., Olsen, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321364111 · Cited by 329
Self-citationThe continuing challenge of ESBLs
PEREZ, F., ENDIMIANI, A., HUJER, K., & BONOMO, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.003 · Cited by 298
Self-citationNew Delhi Metallo-β-Lactamase: Structural Insights into β-Lactam Recognition and Inhibition
King, D. T., Worrall, L. J., Gruninger, R., & Strynadka, N. C. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303579d · Cited by 297
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Bench-to-bedside review: The role of β-lactamases in antibiotic-resistant Gram-negative infections
Bush, K. (2010) · Critical Care · doi:10.1186/cc8892 · Cited by 217
B1-Metallo-β-Lactamases: Where Do We Stand?
F. Mojica, M., A. Bonomo, R., & Fast, W. (2016) · Current Drug Targets · doi:10.2174/1389450116666151001105622 · Cited by 215
Carbapenem-Resistant Strain of Klebsiellaoxytoca Harboring Carbapenem-Hydrolyzingβ-LactamaseKPC-2
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., Bush, K., & Tenover, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3881-3889.2003 · Cited by 187
Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases
Mushtaq, S., Irfan, S., Sarma, J. B., Doumith, M., Pike, R., Pitout, J., Livermore, D. M., & Woodford, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr226 · Cited by 182
Getting to the route of Helicobacter pylori treatment
Goddard, A. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.1.1 · Cited by 172
Structural and Functional Aspects of Class A Carbapenemases
Naas, T., Dortet, L., & I. Iorga, B. (2016) · Current Drug Targets · doi:10.2174/1389450117666160310144501 · Cited by 166
Pérez, F., Chakhtoura, N. G. E., Papp‐Wallace, K. M., Wilson, B. M., & Bonomo, R. A. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1145658 · Cited by 157
Self-citationPoirel, L., Castanheira, M., Carrër, A., Rodriguez, C. P., Jones, R. N., Smayevsky, J., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00022-11 · Cited by 155
Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods
Poirel, L., Bonnin, R. A., & Nordmann, P. (2012) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.02.008 · Cited by 146
Jacoby, G. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1123-1129.2006 · Cited by 129
Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections
Hauck, C. G., Cober, E., Richter, S. S., Pérez, F., Salata, R. A., Kalayjian, R. C., Watkins, R., Scalera, N. M., Doi, Y., Kaye, K. S., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.023 · Cited by 125
Self-citationClass D β-Lactamases: A Reappraisal after Five Decades
Leonard, D. A., Bonomo, R. A., & Powers, R. A. (2013) · Accounts of Chemical Research · doi:10.1021/ar300327a · Cited by 123
Self-citationRichmond, S. M. H. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.677 · Cited by 68
Plasmid Carriage of bla NDM-1 in Clinical Acinetobacter baumannii Isolates from India
Jones, L. S., Toleman, M. A., Weeks, J. L., Howe, R. A., Walsh, T. R., & Kumarasamy, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02500-14 · Cited by 67
Verma, V., Testero, S. A., Amini, K., Wei, W., Liu, J., Balachandran, N., Monoharan, T., Stynes, S., Kotra, L. P., & Golemi, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280115 · Cited by 44
Detection systems for carbapenemase gene identification should include the SME serine carbapenemase
Bush, K., Pannell, M., Lock, J. L., Queenan, A. M., Jorgensen, J. H., Lee, R. M., Lewis, J. S., & Jarrett, D. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.08.008 · Cited by 42
Nguyen, N. Q., Krishnan, N. P., Rojas, L. J., Prati, F., Caselli, E., Romagnoli, C., Bonomo, R. A., & van den Akker, F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02643-15 · Cited by 40
Self-citationFishovitz, J., Taghizadeh, N., Fisher, J. F., Chang, M., & Mobashery, S. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b01374 · Cited by 35
Cited by
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
The Global Ascendency of OXA-48-Type Carbapenemases
Pitout, J. D. D., Peirano, G., Kock, M. M., Strydom, K.-A., & Matsumura, Y. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-19 · Cited by 478
Peirano, G., & Pitout, J. D. D. (2019) · Drugs · doi:10.1007/s40265-019-01180-3 · Cited by 328
Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Baran, A., Kwiatkowska, A., & Potocki, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065777 · Cited by 300
Metadata
- Authors
- Bonomo, R. A.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-10-14
- Volume
- 7
- Issue
- 1
- Pages
- a025239
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2531758255
- Cited by
- 318
- References
- 39
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.